About InViva
Following a 15 year career working in international medical regulation and marketing, within AstraZeneca, Novartis, Fresenius Kabi, and Grifols, InViva Healthcare Management was formed in Yorkshire, UK, as a boutique consultancy initially supporting new product development in pharmaceuticals, medical devices, and tissue based products. Since 2004, InViva has worked on a diverse variety of projects. Examples include the strategy for multiple new candidate cancer therapeutics that can be extracted from plants, the development of novel diagnostic wound dressings, the transfer of technology from the UK to Japan for multi-drug transdermal delivery and more recently, digital medical devices that support critical clinical decision making.
We possess an enviable international network of industry professionals, contacts with Competent Authorities and Notified Bodies, that we can harness, building a customised project around your objectives. Wherever you are within your product’s lifecycle, contact us to see if we can add value.
Why do we exist?
InViva’s missions are to support client growth through their introduction of new medicines, biologics, medical devices, in vitro diagnostics and other healthcare products onto the market, and more established products into new markets. We understand the barriers that small companies face, translating their R&D through complex regulatory pathways for the first time, as well as those that large companies also face, when seeking strategic growth as they cross over into unfamiliar international markets.
InViva can offer full service support with regulatory affairs and quality management which are often seen as unwanted but necessary costs. To counter this, we also offer commercial development support, for example market access, market research, identifying contract manufacturers and distributors helping to monetise projects. We understand common industry barriers, and can take you through them or around them, to help you meet your strategic objectives.
No two companies have exactly the same needs, budgets or timescales. Whether you are undertaking new product development in an SME spinout from a UK university, needing to identify the route to market for CE marking a unique technology in the EU or USA, or you are a major APAC region pharmaceutical company considering entry onto the UK, EU, Europe, or more unfamiliar market, please contact us.
